An update from Allakos Inc (ALLK) is now available.
Allakos Inc. has announced a reshuffling of its Board of Directors, where Daniel Janney and E. Rand Sutherland will not be up for re-election, while Dolca Thomas, M.D. has resigned as a Class I director and is nominated for election as a Class III director. This reorganization aims to balance the board’s composition without any disagreements, changes to compensation, or new agreements. The board will now consist of seven members, with Dr. Thomas’s term set to expire at the 2027 Annual Meeting, and she will continue her involvement in the Research and Clinical Development Committee.
Find detailed analytics on ALLK stock on TipRanks’ Stock Analysis page.
